• 2,5-di-tert-butylbenzene-1,4-diol (BHQ) in Calcium Signaling

  2026-07-01

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) is redefining calcium homeostasis disruption and hematopoietic stem cell mobilization through selective SERCA inhibition. Its validated performance in protocol optimization and translational studies positions APExBIO’s BHQ as a pivotal tool for advanced stem cell and vascular workflows.

• Amitriptyline HCl (B2231): Protocol Guidance for Neuropharma

  2026-07-01

  Amitriptyline HCl, supplied as SKU B2231, enables precise modulation of neurotransmitter receptors in neuropharmacology workflows and model systems where tricyclic antidepressant mechanisms are relevant. It is best reserved for in vitro and ex vivo studies focusing on serotonin, norepinephrine, and related receptor pathways. Its use is not suitable for long-term solution storage or applications requiring ultra-high purity beyond ≥98%.

• Pepstatin A: Mechanistic Leverage for Translational Discover

  2026-06-30

  Explore how Pepstatin A, a potent aspartic protease inhibitor, empowers translational researchers to dissect cell death pathways, viral processing, and osteoclastogenesis. Integrating recent mechanistic insights, including MLKL-driven lysosomal permeabilization and cathepsin activity, this article offers evidence-based protocol guidance and strategic perspectives for maximizing experimental impact.

• IR-1061: Near Infrared Fluorescent Dye for Deep In Vivo Imag

  2026-06-30

  IR-1061 enables ultra-deep tissue imaging with robust NIR-II fluorescence, setting a new standard for optical clarity in biomedical research. This article provides evidence-based workflows, troubleshooting strategies, and protocol enhancements to maximize IR-1061's performance in complex in vivo systems.

• PSMD13 as a Prognostic and Immune Marker in Hepatocellular C

  2026-06-29

  The referenced study systematically identifies PSMD13 as both a prognostic biomarker and a modulator of immune infiltration in hepatocellular carcinoma (LIHC). Using integrative bioinformatics and immunohistochemistry, the authors link PSMD13 upregulation with adverse clinical outcomes and altered immune microenvironments, highlighting its potential for risk stratification and therapeutic targeting in LIHC.

• Anti-Fibrotic Actions of 1-Phenyl-2-Pentanol in Hepatic Stel

  2026-06-29

  This article examines a recent study exploring the anti-fibrotic effects of 1-phenyl-2-pentanol, a compound isolated from Moringa oleifera, on human hepatic stellate cells (HSCs). The research delineates molecular mechanisms underlying fibrosis inhibition, with implications for future gastrointestinal and hepatic physiology research.

• Pepstatin A (SKU A2571): Reliable Aspartic Protease Inhibiti

  2026-06-28

  This article delivers an evidence-based, scenario-driven guide for using Pepstatin A (SKU A2571) as a gold-standard aspartic protease inhibitor in cell viability, proliferation, and cytotoxicity assays. It addresses common laboratory challenges and compares product choices, anchoring practical recommendations to quantitative data and validated protocols. Researchers will find actionable insights for optimizing workflows and ensuring reproducible results with Pepstatin A.

• Stiripentol as an LDH Inhibitor: Optimizing Lactate Metaboli

  2026-06-27

  Stiripentol empowers researchers to precisely modulate lactate metabolism in models of epilepsy and tumor immunometabolism. Its robust LDH inhibition and solubility profile make it the compound of choice for studies on astrocyte-neuron lactate shuttle modulation and histone lactylation-driven immune regulation.

• Doxycycline Hyclate: Strategic MMP Inhibition in Neurovascul

  2026-06-26

  Explore how doxycycline hyclate, a validated matrix metalloproteinases inhibitor, is redefining translational neurovascular research. This article synthesizes mechanistic insights, experimental protocols, and strategic recommendations, focusing on the preservation of blood-brain barrier integrity and cognitive function. Drawing on recent evidence, we discuss the translational value of doxycycline hyclate and offer actionable guidance for researchers navigating the evolving landscape of MMP-targeted therapeutics.

• Capecitabine in Tumor-Targeted Assays: Protocols & Troublesh

  2026-06-26

  Capecitabine, a fluoropyrimidine prodrug, enables apoptosis induction via Fas-dependent pathways and tumor-selective drug delivery in advanced preclinical models. This guide translates cutting-edge assembloid research into actionable workflows, protocol parameters, and troubleshooting strategies for oncology scientists.

• Amitriptyline HCl in High-Throughput BBB and CNS Research

  2026-06-25

  Amitriptyline HCl stands out as a versatile tool for blood-brain barrier (BBB) permeability modeling and neurotransmitter receptor modulation, enabling advanced neuropharmacology research. This guide translates the latest high-throughput in vitro BBB advances into actionable workflows and troubleshooting strategies, accelerating CNS drug discovery with precision.

• CFTRinh-172: Unraveling Selective CFTR Inhibition for Epithe

  2026-06-25

  Explore the unique scientific foundations and translational applications of CFTRinh-172, a selective CFTR inhibitor, in epithelial ion transport research. This article offers a nuanced, mechanism-driven perspective not found in other reviews, empowering researchers to make informed assay and model decisions.

• Angiotensin II in Hypertension Research: Protocols & Innovat

  2026-06-24

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) empowers cardiovascular researchers with unparalleled control over hypertension and vascular remodeling models. Discover how APExBIO’s rigorously validated peptide drives robust workflows, innovative assay design, and troubleshooting for both cell-based and in vivo studies.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-06-23

  This study provides the first in-depth characterization of carbapenemase-encoding gene (CEG) distribution and transmission among carbapenem-resistant Enterobacter cloacae (CREC) isolates from eight teaching hospitals in Guangdong during the COVID-19 era. Key findings reveal frequent plasmid- and chromosome-borne blaNDM-1, high rates of horizontal gene transfer, and significant multidrug resistance, informing future antibacterial research and surveillance strategies.

• Pepstatin A in Immune Cell Protease Research: Precision Tool

  2026-06-23

  Explore how Pepstatin A, a leading aspartic protease inhibitor, enables breakthrough studies of immune cell protease activity in viral and inflammatory diseases. This article offers a unique focus on advanced assay strategies and practical insights for translational research.

16259 records 1/1084 page Next 12345 下5页 Last page